ZEISS invests in Odne to transform root canal treatments

▤ Summary

Odne raised 4.2 million Swiss francs in a Series A1 round led with support from ZEISS Ventures, existing investors, and private and dental investors. The company plans to use the funds to accelerate commercialization and expand into the US market. Odne has FDA clearance for OdneClean, OdneCure, and OdneFill and recently launched at AAE 2025. Its root preservation therapy workflow aims to improve root canal cleaning, reduce complications, and support both specialists and general dentists.

$ Funding

▦ Linked Companies